Affiliation:
1. Sechenov First Moscow State Medical University (Sechenov University)
2. Patrice Lumumba People’s Friendship University of Russia
3. Yeramishantsev City Clinical Hospital
Abstract
Lupus nephritis (LN) is one of the most common organ-specific manifestations of systemic lupus erythematosus (SLE). Various clinical signs of LN develop in at least 50% of patients with SLE. In addition to LN, the spectrum of renal lesions associated with SLE also includes vascular pathology. One of the variants of renal microvascular injury is thrombotic microangiopathy (TMA), the mechanisms of which are diverse. The review focuses on the main forms of TMA, including antiphospholipid syndrome and nephropathy associated with antiphospholipid syndrome, TMA caused by complement system regulation disorders and deficiency of ADAMTS13. In most cases, these forms of TMA are combined with LN. However, they may also exist as a single form of kidney damage. This article discusses the TMA pathogenesis, the impact on kidney prognosis, and treatment options.
Reference47 articles.
1. Клинические рекомендации. Диагностика и лечение волчаночного нефрита. М., 2021. Режим доступа: https://rusnephrology.org/wpcontent/uploads/2021/02/lupus.pdf. Ссылка активна на 16.02.2024 [Klinicheskie rekomendatsii. Diagnostika i lechenie volchanochnogo nefrita. Moscow, 2021. Available at: https://rusnephrology.org/wpcontent/uploads/2021/02/lupus.pdf. Accessed: 16.02.2024 (in Russian)].
2. The frequency and outcome of lupus nephritis: results from an international inception cohort study
3. Lupus nephritis in the XXI century
4. Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis
5. Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions